Browse > Article
http://dx.doi.org/10.9721/KJFST.2012.44.6.653

Hepatoprotective Functions of Sulfur Containing Amino Acids: Possibilities of Hepatocellular Carcinoma Prevention  

Ko, Kwang Suk (Department of Nutritional Science and Food Management, College of Health Science, Ewha Womans University)
Publication Information
Korean Journal of Food Science and Technology / v.44, no.6, 2012 , pp. 653-657 More about this Journal
Abstract
While it is known that sulfur containing amino acids (SCAA) are very important in regulating hepatocyte growth and preventing liver-diseases, the fundamental molecular mechanisms of how they exert their hepatoprotective functions are not well known. Since it is widely understood that the hepatic concentrations of S-adenosylmethionine (SAMe) in chronic liver disease patients are severely decreased, the pathophysiological importance of SAMe and its downstream antioxidant, glutathione should be discussed in order to see a big picture of relationship between SCAA and liver diseases. Chronic SAMe deficient mice have shown spontaneous hepatocellular carcinoma development due to impaired mitochondria functions with low levels of prohibitin1 protein, and through deficiency in many genes which are known to ameliorate genetic instability, such as APEX1 and DUSP1, the functions of which are recovered by SAMe treatment. In this review, current knowledge of the basic concepts of the mechanisms through which SCAAs protect the liver will be discussed in detail. Also, a possible tumor suppressor in livers, prohibitin1, and its functional relationship with SAMe will be discussed.
Keywords
sulfur-containing amino acids; S-adenosylmethionine; glutathione; prohibitin1; liver cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lu SC, Mato JM. S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J. Gastroen. Hepatol. 23(suppl 1): s73-s77 (2008)   DOI   ScienceOn
2 Mato JM, Lu SC. Role of S-adenosyl-L-methionine in liver health and injury. Hepatology 45: 1306-1312 (2007)   DOI   ScienceOn
3 Mudd SH, Poole JR. Labile methyl balances for normal humans of various dietary regimens. Metabolism 24: 721-735 (1975)   DOI   ScienceOn
4 Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, Bain RP, Chawla RK, Bleier JC, Rudman D. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology 81: 668-675 (1981)
5 Kinsell LW, Harper HA, Barton HC, Michaels GD, Weiss HA. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science 106: 589-594 (1947)   DOI
6 Tsukamoto HC, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 15: 1335-1349 (2001)   DOI
7 Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno MT, Carrieri V, Albano O. Effects of oral S-adenosyl-Lmethionine on hepatic glutathione in patients with liver disease. Scand. J. Gastroentero. 24: 407-415 (1989)   DOI
8 Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, Avila MA, Kanel G, Mato JM. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. P. Natl. Acad. Sci. USA 98: 5560-5565 (2001)   DOI
9 Lee TD, Sadda ME, Mendler MH, Bottiglieri T, Kanel G, Mato JM, Lu SC. Abnormal hepatic methionine and GSH metabolism in patients with alcoholic hepatitis. Alcohol Clin. Exp. Res. 28: 173-181 (2004)   DOI
10 Martnez-Chantar ML, Corrales FJ, Martnez-Cruz LA, Garca-Trevijano ER, Huang ZZ, Chen L, Kanel G, Avila MA, Mato MJ, Lu SC. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 16: 1292- 1294 (2002)
11 Santamara E, Avila MA, Latasa MU, Rubio A, Martin-Duce A, Lu SC, Mato JM, Corrales FJ. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of Sadenosylmethionine. P. Natl. Acad. Sci. USA 100: 30653070 (2003)   DOI
12 Sun S, Zhaing H, Xue B, Wu Y, Wang J, Yin Z, Luo L. Protective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in rats. Inflamm Res. 55: 504-510 (2006)   DOI   ScienceOn
13 Tomasi ML, Iglesias-Ara A, Yang H, Ramani K, Feo F, Pascale MR, Martnez-Chantar ML, Mato JM, Lu SC. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: Implication in hepatocarcinogenesis. Gastroenterology 136: 1025- 1036 (2009)   DOI
14 Tomasi ML, Ramani K, Lopitz-Otsoa F, Rodrguez MS, Li TW, Ko K, Yang H, Bardag-Gorce F, Iglesias-Ara A, Feo F, Pascale MR, Mato JM, Lu SC. S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. Hepatology 51: 2152-2161 (2010)   DOI
15 Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 65: 2445-2461 (2005)   DOI
16 Bigatello LM, Broitman SA, Fattori L, Di Paoli M, Pontello M, Bevilacqua G, Nespoli A. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am. J. Gastroenterol. 82: 11-15 (1987)
17 Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. P. Natl. Acad. Sci. USA 94: 2557- 2562 (1997)   DOI   ScienceOn
18 Ko KS, Yang H, Noureddin M, Iglesia-Ara A, Xia M, Wagner C, Luka Z, Mato JM, Lu SC. Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice. Lab. Invest. 88: 1121-1129 (2008)   DOI
19 Yang H, Ramani K, Xia M, Ko KS, Li TW, Oh P, Li J, Lu SC. Dysregulation of glutathione synthesis during cholestasis in mice: Molecular mechanisms and therapeutic implications. Hepatology 49: 1982-1991 (2009)   DOI
20 Ko KS, Tomasi ML, Iglesias-Ara A, French BA, French SW, Ramani K, Lozano JJ, Oh P, He L, Stiles BL, Li TW, Yang H, Martnez-Chantar ML, Mato JM, Lu SC. Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology 52: 2096-2108 (2010)   DOI
21 Nijtmans LG, de Jong L, Artal Sanz M, Coates PJ, Berden JA, Back JW, Muijsers AO, van der Spek H, Grivell LA. Prohibitin act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 19: 2444-2451 (2000)   DOI
22 McClung JK, Danner DB, Stewart DA, Smith JR, Schneider EL, Lumpkin CK, Dell'Orco RT, Nuell MJ. Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem. Bioph. Res. Co. 164: 1316-1322 (1989)   DOI
23 Nijtmans LG, Sanz MA, Grivell LA, Coates PJ. The mitochondrial PHB complex: Roles in mitochondrial respiratory complex assembly, aging, and degenerative disease. Cell. Mol. Life Sci. 59: 143-155 (2002)   DOI
24 Chen XL, Zhou L, Yang J, Shen SP, Zhao SP, Wang YL. Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS. Mol. Med. Rep. 3: 589-596 (2012)
25 Fujinaga H, Tsutsumi T, Yotsuyanagi H, Moriya K, Koike K. Hepatocarcinogenesis in Hepatitic C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology 81(suppl 1): 11-17 (2011)   DOI
26 Wang B, Wang S, Shao C, Wang G, Li Y, Cai L. Proteomic characterization of the late and persistent effects of cadmium at low doses on the rat liver. J. Appl. Toxicol. doi: 10.1002/jat. 1757 [Epub ahead of print] (2011)   DOI
27 Yoo DR, Jang YH, Jeon YK, Kim JY, Jeon W, Choi YJ, Nam MJ. Proteomic identification of anti-cancer proteins in luteolintreated human hepatoma Huh-7 cells. Cancer Lett. 282: 48-54 (2009)   DOI
28 Xu Z, Wu J, Zha X. Up-regulation of prohibitin 1 is involved in the proliferation and migration of liver cancer cells. Sci. China Life Sci. 54: 121-127 (2011)   DOI
29 Snchez-Quiles V, Santamara E, Segura V, Sesma L, Prieto J, Corrales FJ. Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: molecular mechanisms and functional implications. Proteomics 10: 1609-1620 (2010)   DOI
30 Kakehashi A, Ishii N, Shibata T, Wei M, Okazaki E, Tachibana T, Fukushima S, Wanibuchi H. Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis. Toxicol. Sci. 119: 61-72 (2011)   DOI
31 Snchez-Quiles V, Segura V, Bigaud E, He B, O'Malley BW, Santamara E, Prieto J, Corrales FJ. Prohibitin-1 deficiency promotes inflammation and increases sensitivity to liver injury. J. Proteomics. 75: 5783-5792 (2012)   DOI
32 Surh YJ. Cancer Chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3: 768-780 (2003)   DOI   ScienceOn
33 Oz HS, Chen TS, Neuman M. Methionine deficiency and hepatic injury in a dietary steatohepatitis model. Digest. Dis. Sci. 53: 767-776 (2008)   DOI
34 Young SN, Shalchi M. The effect of methionine and S-adenosylmethionine on S-adenosylmethionine level in the rat brain. J. Psychiat. Neurosci. 30: 44-48 (2005)
35 Martnez-Chantar ML, Vzquez-Chantada M, Ariz U, Martnez N, Varela M, Luka Z, Capdevila A, Rodrguez J, Aransay AM, Matthiesen R, Yang H, Calvisi DF, Esteller M, Fraga M, Lu SC, Wagner C, Mato JM. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 47: 1191-1199 (2008)